Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study

K. Antoniou (Herakleion, Greece), A. Trachalaki (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), G. Papastratigakis (Herakleion, Greece), E. Bibaki (Herakleion, Greece), E. Stamataki (Herakleion, Greece), G. Meletis (Herakleion, Greece), N. Tzanakis (Herakleion, Greece)

Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Session: Management of idiopathic interstitial pneumonias: established and new treatments
Session type: Thematic Poster
Number: 4787
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Antoniou (Herakleion, Greece), A. Trachalaki (Herakleion, Greece), E. Vasarmidi (Herakleion, Greece), G. Margaritopoulos (London, United Kingdom), G. Papastratigakis (Herakleion, Greece), E. Bibaki (Herakleion, Greece), E. Stamataki (Herakleion, Greece), G. Meletis (Herakleion, Greece), N. Tzanakis (Herakleion, Greece). Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study. 4787

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data
Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Year: 2017



Asthma control and quality of life in asthmatic patients treated for 6 months with FDC Budesonide/Formoterol - BOREAS study: a subgroup analysis in patients with comorbidities
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


The results of asthma in real life (ARL) study in Poland
Source: Eur Respir J 2001; 18: Suppl. 33, 45s
Year: 2001

Decline in function in preclinical COPD patients: a 6 years follow up study.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017



Does one year change in quality of life predict the mortality in patients with COPD?: Prospective cohort study
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

Incidence of COPD in a sample of patients with psychosis: preliminary data from a 10 years longitudinal study
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017

How far is real life from COPD therapy guidelines? An observational study on 4000 patients in Italy
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Characterization of exercise impairment in relation to quality of life (QoL) and hospital admission in COPD patients; data from the INTERCOM trial
Source: Eur Respir J 2005; 26: Suppl. 49, 433s
Year: 2005

Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


A real life multicenter national study on the use of nintedanib in moderate to severe IPF patients
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Two years’ follow-up with real life quantitative measurement of ambulation under oxygen therapy in patients with chronic respiratory disease (ACTIMETRE study).
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018

2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Survival analysis of PAH patients based on a multidimensional risk approach at baseline in Uruguay: 10 years of experience of a PH referral centre.
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Intensive care results and costs of advanced age patients with respiratory failure: 3 years cohort study
Source: Annual Congress 2011 - Intensive care outcome
Year: 2011


Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort
Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations
Year: 2013

LATE-BREAKING ABSTRACT: A 2 year follow up randomized pilot study of a care on demand system in COPD patients.
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013